- CH₣252.66bn
- CH₣285.31bn
- $56.33bn
European shares rise as Democrats take US Congress, Novo Nordisk surges
European shares rise as Democratic sweep lifts clean energy, bank stocks
Europe set to open lower as Democratic sweep fuels AI regulation fears
Brief: Bioarctic Says Novartis Terminates Option, Collaboration And License Agreement With Bioarctic
Preview: Novartis heart drug failure leaves doctors seeking evidence for genetic cholesterol target
Swiss stocks - Factors to watch on November 2
Brief: EMA Says European Commission Withdraws Marketing Authorisation For Hirobriz Breezhaler On Oct 30, 2026
Health Rounds: Rise in US colon cancer rates not limited to young adults, analysis finds
Health Rounds: Rise in US colon cancer rates not limited to young adults, analysis finds (updated)
Health Rounds: Colon cancer rates are rising among all US adults, analysis finds
Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge (updated)
Corrected: UPDATE 1-Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge
Corrected: Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge
Swiss biotech firm Molecular Partners to cut nearly half of workforce
Swiss stocks - Factors to watch on October 29
Europe Research Roundup: Fidelity Emerging Markets, INFICON Holding, Novartis
Swiss stocks - Factors to watch on October 28
Press Digest: Financial Times - October 28
European shares shrug off HSBC miss as other earnings, oil relief lift sentiment